Relx Plc (RELX) - What Are Researchers Thinking About This Stock?

Key Points

• Analysts are broadly positive on RELX: Of 14 analysts covering the stock, 10 rate it a “Buy,” two rate it a “Strong Buy,” and two recommend holding it.
• RELX opened at $39.24, above its 50-day moving average of $35.02 and 200-day moving average of $34.28, but remains below its 12-month high of $47.22.
• Institutional investors own approximately 15.02% of the stock, while the company recently reduced its dividend from $0.6559 to $0.2785 per share.

Relx Plc (NYSE:RELX - Get Free Report) has earned an average recommendation of "Buy" from the fourteen analysts that are presently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation, ten have given a buy recommendation and two have assigned a strong buy recommendation to the company.

RELX has been the topic of a number of analyst reports. Zacks Research raised Relx from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, September 30th. Barclays reiterated an "overweight" rating on shares of Relx in a research note on Friday, July 24th. UBS Group reissued a "buy" rating on shares of Relx in a research report on Tuesday, September 29th. TD Securities raised shares of Relx to a "strong-buy" rating in a report on Friday, September 11th. Finally, Sanford C. Bernstein reaffirmed a "buy" rating on shares of Relx in a report on Tuesday, October 6th.

Relx Price Performance

RELX opened at $39.24 on Tuesday. Relx has a 12 month low of $27.57 and a 12 month high of $47.22. The company has a debt-to-equity ratio of 5.23, a current ratio of 0.45 and a quick ratio of 0.40. The business has a fifty day moving average price of $35.02 and a 200 day moving average price of $34.28.

Relx Cuts Dividend

The company also recently declared a dividend, which was paid on Tuesday, September 15th. Shareholders of record on Friday, August 7th were issued a dividend of $0.2785 per share. This is a drop from Relx's previous dividend of $0.6559. The ex-dividend date was Friday, August 7th. This represents a yield of 157.0%.

Institutional Investors Weigh In On Relx

A number of large investors have recently modified their holdings of the company. Whipplewood Advisors LLC raised its holdings in Relx by 2,468.4% during the first quarter. Whipplewood Advisors LLC now owns 976 shares of the technology company's stock worth $32,000 after purchasing an additional 938 shares in the last quarter. V Square Quantitative Management LLC purchased a new stake in shares of Relx during the 1st quarter worth approximately $44,000. First Horizon Corp lifted its position in shares of Relx by 41.0% during the 1st quarter. First Horizon Corp now owns 1,352 shares of the technology company's stock worth $45,000 after buying an additional 393 shares during the last quarter. Integrated Wealth Concepts LLC acquired a new position in shares of Relx in the 2nd quarter valued at $77,000. Finally, GHP Investment Advisors Inc. acquired a new position in shares of Relx in the 1st quarter valued at $93,000. 15.02% of the stock is owned by hedge funds and other institutional investors.

Relx Company Profile

RELX PLC is a global information-based analytics and decision tools company serving professional and business customers. The company provides data, software, research, and workflow solutions that help organizations make decisions, manage risk, improve productivity, and access specialized knowledge.

Its main business areas include scientific, technical, and medical information; risk and business analytics; legal information and technology; and industry-focused events. Products and services include research platforms such as ScienceDirect and Scopus, legal research and workflow solutions offered through LexisNexis, and risk-management, fraud-prevention, and identity solutions provided through LexisNexis Risk Solutions.

RELX serves customers internationally, including universities, researchers, law firms, government agencies, insurers, financial institutions, corporations, and healthcare professionals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.